Purdue unit sued over patent extension for opioid Targin

Healthcare 2022-11-24 11:53 pmBy Cindy Cameronne | Sydney

Please login to bookmark

Australian pharmaceutical company AUPharma has sued the international arm of Purdue, alleging it was wrongly granted patent extensions for several oxycodone products marketed as Targin.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au